Unknown OBSERVATIONAL NCT03904004

Pressure and Flow Study Before and After Treatments for EMD. The pFlow Study (pFlow)

Impact of Peroral Endoscopic Myotomy and Other Treatments for Oesophageal Motility Disorders on Bolus Transport and Gastro-oesophageal Reflux. The pFlow Study

Sponsor: Fundacion Miguel Servet

Conditions Esophageal Motility Disorders Gastro-esophageal Reflux

Interventions Botulinum toxin injection Laparoscopic Heller Myotomy Neumatic dilatation Peroral endoscopic myotomy

Updated 5 times since 2019 Last updated: Apr 8, 2019 Started: May 15, 2019 Primary completion: May 31, 2020 Completion: Jun 30, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03904004, this observational or N/A phase trial focuses on Esophageal Motility Disorders and Gastro-esophageal Reflux and remains ongoing. Sponsored by Fundacion Miguel Servet, it has been updated 5 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jul 2022 — Jul 2024 [monthly]

Unknown Status

Status: Not Yet Recruiting → Unknown Status
Jan 2021 — Jul 2022 [monthly]

Not Yet Recruiting
May 2019 — Jan 2021 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fundacion Miguel Servet

Data source: Fundacion Miguel Servet

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pamplona, Spain